About CSL
CSL Behring is one of the world's leading manufacturers of plasma derivatives. The company supplies the global market with its products and produces almost a fifth of all plasma-based drugs worldwide. CSL Behring offers over 26 products in indication areas such as coagulation disorders, immunodeficiencies, wound healing and intensive care medicine.
Human blood plasma contains numerous ingredients that are difficult or impossible to produce artificially. The manufacture of plasma products is therefore dependent on people who donate blood plasma. Vital medicines are produced from it. For a person with congenital haemophilia, even a minor bleed can be life-threatening. The immune system can be so weakened that infections in the body can no longer be fought off. Severely injured people and burn victims struggle with blood and plasma loss. In these cases, donated blood plasma can save lives or enable a largely symptom-free life. An innovative pipeline will also ensure that patients all over the world receive the best possible care in the future.
In Germany, CSL Behring supplies patients with 21 different plasma-based drugs, a recombinant factor VIII preparation, a fibrinolytic, a heparin preparation and a vasopressin analog. The company therefore has the broadest range of plasma derivatives and comparable products.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
